GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Profit & Loss Account Balance History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Profit & Loss Account Balance | ₹7,157 Cr | ₹6,788 Cr | ₹6,015 Cr | ₹5,234 Cr | ₹4,023 Cr |
What is the latest Profit & Loss Account Balance ratio of GLAND PHARMA ?
Year | Profit & Loss Account Balance |
---|---|
Mar2025 | ₹7,157 Cr |
Mar2024 | ₹6,788 Cr |
Mar2023 | ₹6,015 Cr |
Mar2022 | ₹5,234 Cr |
Mar2021 | ₹4,023 Cr |
How is Profit & Loss Account Balance of GLAND PHARMA Trending?
Years | Profit & Loss Account Balance | % Change | |
---|---|---|---|
Mar2025 | ₹7,157 Cr | 5.44 | |
Mar2024 | ₹6,788 Cr | 12.84 | |
Mar2023 | ₹6,015 Cr | 14.92 | |
Mar2022 | ₹5,234 Cr | 30.12 | |
Mar2021 | ₹4,023 Cr | - |
Compare Profit & Loss Account Balance of peers of GLAND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAND PHARMA | ₹33,253.3 Cr | 1.5% | 3% | 11.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹391,368.0 Cr | 0.7% | -0.7% | -11% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,631.0 Cr | NA | -1.6% | 12.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,641.0 Cr | 3.1% | -0.9% | 9.1% | Stock Analytics | |
CIPLA | ₹123,419.0 Cr | -2% | -4% | -5.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,176.0 Cr | -0.2% | 2.4% | 0% | Stock Analytics |
GLAND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAND PHARMA | 1.5% |
3% |
11.5% |
SENSEX | -0.3% |
0.1% |
-1% |
You may also like the below Video Courses